Mucolipidosis type IV is a neurodegenerative lysosomal disease clinically characterized by psychomotor retardation, visual impairment, and achlorhydria. In this study we report the development of a neuronal cell model generated from cerebrum of neuronal cultures, indicating that the lack of mucolipin-1 affects LC3-II clearance. P62/SQSTM1 and ubiquitin levels were also increased in Mcoln1 −/− neuronal cultures, suggesting an accumulation of protein aggregates and a defect in macroautophagy which could help explain the neurodegeneration observed in MLIV. This study describes, for the first time, a defect in macroautophagy in mucolipin-1-deficient neurons, which corroborates recent findings in MLIV fibroblasts and provides new insight into the neuronal pathogenesis of this disease.
Introduction
Mucolipidosis type IV (MLIV; OMIM 252650) is a progressive neurological lysosomal disease that usually presents during the first year of life with mental retardation, corneal opacities, elevated blood gastrin levels with achlorhydria, and delayed motor milestones (Berman et al., 1974; Frei et al., 1998) . MLIV is an autosomal recessive disease with the majority of the cases (80%) reported in individuals of Ashkenazi Jewish (AJ) descent (Bargal et al., 2000) . The carrier frequency in AJ is estimated to be 1:100 and the major AJ mutation, present on 72% of the AJ MLIV alleles, is an A-G transition at the 3′ acceptor site of intron 3 (Bargal et al., 2000; Bassi et al., 2000; Sun et al., 2000) . The minor AJ mutation, found on 23% of the AJ MLIV alleles, is a 6434 bp genomic deletion that spans exons 1-6 and the first 12 bp of exon 7 (Goldin et al., 2004; Wang et al., 2002) .
The MCOLN1-encoded protein (mucolipin-1, TRPML1) is a transmembrane protein with topological homology to other members of the TRP superfamily of ion channels. Several studies have begun to shed light on the function of mucolipin-1 as a calcium channel, however, the pathogenic mechanism by which loss of mucolipin-1 leads to cellular storage and neuronal cell dysfunction and death in MLIV is still poorly understood (Kiselyov et al., 2005; LaPlante et al., 2002 LaPlante et al., , 2006 Manzoni et al., 2004; Miedel et al., 2006; Pryor et al., 2006; Thompson et al., 2007; Venkatachalam et al., 2006; Vergarajauregui and Puertollano, 2006) .
Recently, an increased association between lysosomal diseases and macroautophagy dysfunction has been described. Macroautophagy is a constitutive, well orchestrated process responsible for bulk degradation of long-lived proteins and cellular organelles. Macroautophagy is essential for the survival of neural cells and its impairment is implicated in the pathogenesis of neurodegenerative disorders (Komatsu et al., 2006; Nedelsky et al., 2008; Ventruti and Cuervo, 2007) . In some lysosomal diseases, the observed autophagic stress is also correlated with neuronal death and could be linked to the neurodegeneration, although the full extent of neuronal death in most lysosomal diseases has not yet been determined (Cao et al., 2006; Neurobiology of Disease 40 (2010) 370-377 
